InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,264.40
(
0.00%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.79
(
0.43%
)
Bitcoin
61,440.36
(
-0.28%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: None

Wednesday, 01/07/2015 8:35:35 AM

Wednesday, January 07, 2015 8:35:35 AM

Post# of 252412
ENTA to present preclinical NASH data at JPM conference on 1/14

http://uk.advfn.com/news/BW/2015/article/65014300?xref=newsalerttweet&adw=1126416

Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present a corporate overview that will include an update on Enanta’s development pipeline, including preclinical data from Enanta’s new research program in non-alcoholic steatohepatitis (NASH), on January 14, 2015 at 11:00 a.m. PT during the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up